Multiplex Polymerase Chain Reaction (PCR)
To evaluate and monitor the bone marrow engraftment status after the transplant.
Interpretive report provided.
If the patient has a very low white blood cell count, the DNA yield may be insufficient to complete the analysis. A BMT pre-transplant analysis must have been done and polymorphism detected in order to perform this test. Both the patient's pre-transplant and the donor's specimen must be available. Specimens submitted for Molecular Diagnostics testing may contain substances that can inhibit PCR gene amplification. If an inhibitor is known to be present, attempts will be made to clear the specimen of inhibitor prior to amplification. Known inhibitors include heparin, medications and some levels of hemoglobin or IgG. The major inhibitor we see in our laboratory is heparin; avoid drawing blood in a heparin tube or through a heparinized port. For molecular diagnostics testing, a lavender top (EDTA) tube is preferred. If specimens containing heparin must be submitted, note "heparin" on the requisition to alert the lab to 'clean' the specimen before analysis thus reducing turnaround time, improving retention of DNA in the specimen and increasing our ability to return a conclusive result.
2 - 7 days
- Bone Marrow Transplant Engraftment Evaluation
- Engraftment Status Evaluation
- Post-BMT Engraftment Analysis
- VNTR for post-BMT Engraftment Analysis
- Post BM Engraph. Eval
- Chimerism Analysis, Post-Transplant
Collect blood or bone marrow in lavender top tube. Send intact specimen at room temperature or refrigerated.
By ordering this test the clinician acknowledges that informed consent has been obtained from the patient as required by applicable state or federal laws and the ordering clinician has authorization from the patient permitting MLabs to report the test results to the ordering clinician. Test includes pathologist interpretation of results billed as a separate additional charge. This test is not available without interpretation.